View:
Download DOC
Download PDF
SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Burton Karen L
(Last) (First) (Middle)
C/O CHANCERY HOUSE, 190 WATERSIDE RD.
HAMILTON INDUSTRIAL PARK
(Street)
LEICESTER X0 LE5 1QZ
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/26/2017 		3. Issuer Name and Ticker or Trading Symbol
Steris plc [ STE ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP, Controller & CAO
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares, 0.10 par value 8,726(1) D
Ordinary Shares, 0.10 par value 319(2) I By 401(k)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) (3) 05/21/2018 Ordinary Shares 475 30.84 D
Employee Stock Option (right to buy) (4) 05/20/2020 Ordinary Shares 3,800 31.87 D
Employee Stock Option (right to buy) (5) 05/31/2021 Ordinary Shares 3,800 36.09 D
Employee Stock Option (right to buy) (6) 05/30/2022 Ordinary Shares 3,700 29.94 D
Employee Stock Option (right to buy) (7) 05/31/2023 Ordinary Shares 4,040 45.34 D
Employee Stock Option (right to buy) (8) 05/30/2024 Ordinary Shares 3,400 53.52 D
Employee Stock Option (right to buy) (9) 05/28/2025 Ordinary Shares 2,852 66.15 D
Employee Stock Option (right to buy) (10) 06/01/2026 Ordinary Shares 2,600 69.72 D
Explanation of Responses:
1. 5,956 of these shares are restricted and vest as follows: 1,300 on May 31, 2017; 1,000 on April 2, 2018; 972 on May 30, 2018; 764 on May 28, 2019; 700 on October 1, 2019 and 1,220 on June 1, 2020.
2. Based on closing price of February 2, 2017.
3. This option was granted as part of an award of 2,100 ordinary shares on May 21, 2008, 1,625 of which has been exercised.
4. This option was granted on May 20, 2010 and is fully vested.
5. This option was granted on May 31, 2011 and is fully vested.
6. This option was granted on May 30, 2012 and is fully vested.
7. This option was granted on May 31, 2013 and is exerciseable in four equal amounts as follows: 1,010 on May 31, 2014, 1,010 on May 31, 2015, 1,010 on May 31, 2016 and 1,010 on May 31, 2017.
8. This option was granted on May 30, 2014 and is exerciseable in four equal amounts as follows: 850 on May 30, 2015, 850 on May 30, 2016, 850 on May 30, 2017 and 850 on May 30, 2018.
9. This option was granted on May 28, 2015 and is exerciseable in four equal amounts as follows: 713 on May 28, 2016, 713 on May 30, 2017, 713 on May 29, 2018 and 713 on May 28, 2019.
10. This option was granted on June 1, 2016 and is exerciseable in four equal amounts as follows: 650 on June 1, 2017, 650 on June 1, 2018, 650 on June 3, 2019 and 650 on June 1, 2020.
Remarks:
Vice President, Controller and Chief Accounting Officer Exhibit 24 - Power of Attorney
/s/ Ronald E. Snyder, Authorized Representative under Power of Attorney 02/03/2017
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Securities and Exchange Commission Washington, D.C. 20549

RE:	STERIS plc
Commission File No. 001-37614
1933 Act and 1934 Act Filings
Authorized Representatives

Ladies and Gentlemen:

The above Company is or will be the issuer of securities registered under
Section 12 of the Securities Exchange Act of 1934. The undersigned confirms, as
of the date appearing opposite his/her signature, that each of the "Authorized
Representatives" named below is authorized on his/her behalf to sign such
statements (on Form 3, Form 4, Form 5, Form 144, Schedule 13G, Form ID (if
necessary) or otherwise, collectively, "Forms") with respect to securities of
the Company (the "Securities"), and to submit to the Securities and Exchange
Commission such Forms (including reports, notices, and other statements) with
respect to the Securities, as are required by the Securities Act of 1933, as
amended, or the Securities Exchange Act of 1934 as amended (collectively, the
"Acts").  The undersigned also confirms the authority of each of the Authorized
Representatives to do and perform, on his/her behalf, any and all acts and
things with respect to the Securities requisite or necessary to assure
compliance by the undersigned with the filing requirements of the Acts.

This authority revokes all prior authorities with respect to the Securities
previously executed by the undersigned including but not limited to any such
authorities filed with or given to the Commission by the undersigned. This
authority contained herein shall remain in full force and effect until the
undersigned is no longer required to file Forms with respect to the
undersigned's holdings of and transactions in the Securities, unless earlier
revoked by the undersigned in a signed writing delivered to the Authorized
Representatives.

Authorized Representatives
Judith A. Hunter
Julia Kipnis
Rebecca A. Nichols
Ronald E. Snyder
Michael J. Tokich
J. Adam Zangerle

The undersigned acknowledges that the foregoing Authorized Representatives, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with the Acts.  Additionally, although pursuant to this authority, the
Authorized Representatives will use commercially reasonable efforts to timely
and accurately file the required Forms on behalf of the undersigned, the
Authorized Representatives do not represent or warrant that they will be able to
in all cases timely and accurately file such Forms on behalf of the undersigned
due to various factors and the undersigned and the Authorized Representatives'
need to rely on others for information, including the undersigned and brokers of
the undersigned.


Dated:  January 30, 2017				By:/s/ Karen L. Burton
                                                        Signature

							Karen L. Burton
                                                        Printed Name